ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Taysha Gene Therapies Inc

Taysha Gene Therapies Inc (TSHA)

2.48
0.10
(4.20%)
Closed December 08 3:00PM
2.52
0.04
(1.61%)
After Hours: 6:39PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.52
Bid
2.20
Ask
4.15
Volume
2,182,114
2.385 Day's Range 2.56
1.19 52 Week Range 4.32
Market Cap
Previous Close
2.38
Open
2.40
Last Trade Time
Financial Volume
US$ 5,413,105
VWAP
2.4807
Average Volume (3m)
4,249,977
Shares Outstanding
204,943,306
Dividend Yield
-
PE Ratio
-4.54
Earnings Per Share (EPS)
-0.54
Revenue
15.45M
Net Profit
-111.57M

About Taysha Gene Therapies Inc

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and com... Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Dover, Delaware, USA
Founded
-
Taysha Gene Therapies Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TSHA. The last closing price for Taysha Gene Therapies was US$2.38. Over the last year, Taysha Gene Therapies shares have traded in a share price range of US$ 1.19 to US$ 4.32.

Taysha Gene Therapies currently has 204,943,306 shares outstanding. The market capitalization of Taysha Gene Therapies is US$487.77 million. Taysha Gene Therapies has a price to earnings ratio (PE ratio) of -4.54.

TSHA Latest News

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus...

Taysha Gene Therapies Reports Third Quarter 2024 Financial Results and Provides Corporate Update

High dose TSHA-102 was generally well tolerated with no SAEs or DLTs in two adolescent/adult patients and one pediatric patient as of data cutoff; IDMC approved continued enrollment in cohort two...

Taysha Gene Therapies to Release Third Quarter 2024 Financial Results and Host Conference Call and Webcast On November 13

DALLAS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene...

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus...

Taysha Gene Therapies to Present Biodistribution Data from an Analysis Evaluating AAV9 Gene Therapy Delivery at the Upcoming 31st Annual ESGCT Congress

Data from an analysis of five NHP studies showed lumbar IT administration led to widespread and consistent biodistribution of AAV9 gene therapy vectors across brain and spinal cord regions IT and...

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

DALLAS, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene...

Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress

DALLAS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.495-16.41791044783.0153.312.255009372.72017195CS
41.177.46478873241.423.311.476619942.39588259CS
120.300113.51862696522.21993.311.1942499772.13372695CS
26-1.48-3744.321.1931694702.27968881CS
520.72401.84.321.1927687332.36597576CS
156-10.135-80.086922165212.65515.340.518172312.42510631CS
260-19.73-88.674157303422.2533.840.513346483.01347181CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UPCUniverse Pharmaceuticals Inc
US$ 3.38
(221.90%)
93.72M
LIFWMSP Recovery Inc
US$ 3.2461
(104.16%)
29.08M
GXAIGaxos ai Inc
US$ 2.5801
(81.70%)
146.21M
SBETSharpLink Gaming Inc
US$ 0.9116
(73.97%)
27.09M
HCTIHealthcare Triangle Inc
US$ 1.165
(68.38%)
4.34M
ORISOriental Rise Holdings Ltd
US$ 3.6833
(-93.42%)
27.51M
LICNLichen China Limited
US$ 0.4895
(-76.91%)
185.96M
MYNAMynaric AG
US$ 0.499246
(-64.59%)
3.6M
CEROCERo Therapeutics Holdings Inc
US$ 0.1146
(-40.16%)
37.87M
BTCTBTC Digital Ltd
US$ 10.50
(-32.95%)
3.26M
SMXSMX Security Matters Public Company
US$ 0.4879
(64.06%)
440.04M
SOUNSoundHound AI Inc
US$ 15.01
(12.60%)
215.93M
LICNLichen China Limited
US$ 0.4895
(-76.91%)
185.96M
NVDANVIDIA Corporation
US$ 142.44
(-1.81%)
185.41M
SVMHSRIVARU Holding Ltd
US$ 0.0293
(-16.29%)
160.45M

TSHA Discussion

View Posts
glenn1919 glenn1919 16 hours ago
TSHA.....................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 2 weeks ago
TSHA..............https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
georgie18 georgie18 3 weeks ago
TSHA...$2.58...Off the $2.10 Alert...🥳

georgie18

Member Level
Re: georgie18 post# 85

Tuesday, November 12, 2024 3:56:56 PM

Post#
89
of 90
TSHA...$2.41...🥳...on the $2.10 gapper alert...All out for now...will revisit...

georgie18

Member Level
Re: None

Monday, November 11, 2024 5:18:23 PM

Post#
664504
of 664675
TSHA...$2.10... https://schrts.co/KsMDABsM ...Psar flipped Bullish...🥳Should be a gapper in the morning...
πŸ‘οΈ0
glenn1919 glenn1919 4 weeks ago
TSHA............................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
georgie18 georgie18 4 weeks ago
TSHA...$2.41...🥳...on the $2.10 gapper alert...All out for now...will revisit...

georgie18

Member Level
Re: None

Monday, November 11, 2024 5:18:23 PM

Post#
664504
of 664675
TSHA...$2.10... https://schrts.co/KsMDABsM ...Psar flipped Bullish...🥳Should be a gapper in the morning...
πŸ‘οΈ0
zendeli1 zendeli1 4 weeks ago
restart soon
πŸ‘οΈ0
glenn1919 glenn1919 4 weeks ago
TSHA....................................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
glenn1919 glenn1919 4 weeks ago
TSHA.................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
georgie18 georgie18 4 weeks ago
TSHA...$2.10... https://schrts.co/KsMDABsM ...Psar flipped Bullish...🥳Should be a gapper in the morning...
πŸ‘οΈ0
nsomniyak nsomniyak 4 weeks ago
I sent an email to TSHA IR on 11/5 asking if they could explain the sharp drop (at that time) and high volume in the stock. I did not receive an answer.
πŸ‘οΈ0
nsomniyak nsomniyak 4 weeks ago
Premiums were high all last week and today on TSHA call options. Volume in the common has been high as well.
πŸ‘οΈ0
Pip611 Pip611 4 weeks ago
I was thinking the same thing, it started to pop in the afternoon and now it took off after hours
πŸ‘οΈ0
nsomniyak nsomniyak 4 weeks ago
What is going on with TSHA in the AH today? Up sharply - now 2.10
πŸ‘οΈ0
Monksdream Monksdream 2 months ago
TSHA under $3
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
TSHA under $3
πŸ‘οΈ0
TechandBio TechandBio 5 months ago
Started buying shares last year at .77 Riding the houses money now and sold three quarters of my shares at $4.00 range when I saw the double top formation come into play I can see this going to $8.00-$10.00 only on a buyout in the next year. Risky with only a handful of patients dosed and the competition for Rhett but a cunning bet with the management at TSHA. now.
CEO and CMO are best in class. Not a core position but glad I'm in with a few. I hope they have a remedy for these poor kids with Rhett.

$TSHA
πŸ‘οΈ0
nsomniyak nsomniyak 5 months ago
If these are senior people in prominent management or technical roles it is pretty standard for them to be granted options as part of their compensation package. They vest over 4 years, so it is not an outright giveaway.

Additionally, since these are NEW employees, by definition they have not manipulated the stock down to get a lower option strike price.

I am fine with this very normal comp package.
👍️ 1
ErnieBilco ErnieBilco 5 months ago
I'm sorry but granting options to NEW employees is absurd - they shouldn't be entitled to stock options UNTIL their one year on the job.

No wonder why this has trouble making gains for shareholders whom the employees actually work for.
πŸ‘οΈ0
LegendaryNomad22 LegendaryNomad22 6 months ago
Weird. Both TSHA and NGNE have gene therapy candidates for Rett and both of them tanked today, despite sharing strong interim results. There's an International Rett Syndrome Foundation meeting today and tomorrow, so I wonder if something happened there to take the wind out of the gene therapy treatment class. Anyone have any knowledge here?
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
Diluted on news
πŸ‘οΈ0
Pip611 Pip611 6 months ago
Ouch - what happen?
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
TSHA...GAPPING
πŸ‘οΈ0
Tiger Money Tiger Money 6 months ago
Yes, no sorry, didn’t mean to imply that. I was asking if you have other bio names you have on your radar (obviously know about this and Huma). Thanks
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
chart has nothing to do with what sector!!
πŸ‘οΈ0
Tiger Money Tiger Money 6 months ago
You have the bios nailed down! Any I should put on my radar? As always, thank you as I sincerely appreciate your help and knowledge. Thanks!
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
TSHA BREAK OUT
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
TSHA new 52 week high
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
TSHA...HERES 4 DOLLA
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
TSHA...READY FOR 4
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
TSHA...BIO BEAST BREAKING HEWRE CHAINS
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
TSHA HERE WE GO ON THE BREAK OUT!!
πŸ‘οΈ0
glenn1919 glenn1919 6 months ago
TSHA......................................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
TSHA HERE COMES THE BREAK
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 6 months ago
TSHA...NEXT BIO READY TO BEAST!
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 6 months ago
Taysha may have the real ONE-SHOT genetic cure. It may REALLY work.
Good luck getting any health insurance plan to list this $Million dollar shot in their drug formulary.
πŸ‘οΈ0
Monksdream Monksdream 6 months ago
TSHA under $5
πŸ‘οΈ0
glenn1919 glenn1919 9 months ago
TSHA..............................https://stockcharts.com/h-sc/ui?s=TSHA&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
TSHA..READY TO PUSH TO 4.00
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
TSHA...MONSTER
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
TSHA...HERE WE GO
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
TSHA..here we go
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
TSHA...MONSTER
πŸ‘οΈ0
TrendTrade2016 TrendTrade2016 9 months ago
TSHA NEXT BIO BEAST TO RUN TO 3.61 WATCH THE MAGIC
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 11 months ago
β€œDosing the first pediatric patient with Rett syndrome marks an important step forward in our efforts to broaden the clinical evaluation of TSHA-102 to younger patients with earlier stages of Rett syndrome. We are pleased with our progress on expanding the study of TSHA-102 across a broad population of ages and stages of Rett syndrome to bring a potentially transformative treatment option to all patients and families suffering from this devastating disease,” said Sukumar Nagendran, M.D., President, and Head of R&D of Taysha. β€œThe pediatric trial will build on our ongoing REVEAL adolescent and adult trial, where early data demonstrated improvements across multiple clinical domains in adult patients with the most advanced stage of disease. We also plan to expand our U.S. pediatric trial into the U.K. following the recent acceptance of our CTA by the MHRA.”
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 1 year ago
Estimated Enrollment : 18 participants
(was 12).
https://classic.clinicaltrials.gov/ct2/show/NCT05606614
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 1 year ago
β€œFollowing review of the initial clinical data from the first two adult patients treated with TSHA-102 and Chemistry, Manufacturing, and Controls (CMC) data, Health Canada has authorized our protocol amendment to include adolescent patients aged 12 years and older in the ongoing REVEAL Phase 1/2 adult trial,”
https://ih.advfn.com/stock-market/NASDAQ/taysha-gene-therapies-TSHA/stock-news/92678004/taysha-gene-therapies-announces-expanded-eligibili
πŸ‘οΈ0
FooBarAndGrill FooBarAndGrill 1 year ago
The P1 TSHA-102 REVEAL Adult Study has been on a slow boat.
Hopefully, the Clinical Updates PR will give the push to finally complete enrollment of the 12 adult female Rett patients needed for the trial.
I'm guessing reluctance to enroll has been based on the one-time injection into the intrathecal space (directly into the Cerebral Spinal Fluid).
It's definitely worth the risk, IMO. Good Luck to All.
πŸ‘οΈ0
bikaver bikaver 1 year ago
TSHA.....Definitely headed in the right direction now. A couple more days of downward momo would be great.
πŸ‘οΈ0
make it happen make it happen 1 year ago
Cannacord Genuity and Truist Securities both lowered there price targets, never a good thing...
πŸ‘οΈ0
make it happen make it happen 1 year ago
Think it's about there. I believe we flush under $3.00 and don't come back to the this price per share PPS till R/S. A ways away but see it happening. JMHO
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock